1Shoker BS,Jarvis C,Clarke RB,et al.Abnormal regulation of the oestrogen receptor in benign breast lesions[J].J Clin Pathol.2000;53(10):778–83.
2Pine JW,McG ough J,editors.Rosen’s breast pathology.3rd ed.Philadelphia:Lippincott Williams and Wilkins;2009.p.285–357.
3Chan JK,Ng WF.Sclerosing adenosis cancerized by intraductal carcinoma[J].Pathology,1987,19(14):425–428.
4Eusebi V,Collina G,Bussolati G.Carcinoma in situ in sclerosing adenosis of the breast:an immunocytochemical study[J].Semin Diagn Pathol,1989,6(2):146-152.
5Yoshida,A Hayashi N,F Akiyama F,et al.Ductal carcinoma in situ that involves sclerosing adenosis:high frequency of bilateral breast cancer occurrence[J].Cli B reast Cancer,2012,12(6):398-403.
6Ogura K,Horii R,Oosako T,et al.A clinico-pathological study on cancer in sclerosing adenosis[J].Breast Cancer,2014,21(6):732-737.
7Visscher DW,Nassar A,Degnim AC,et al.Sclerosing adenosis and risk of breast cancer[J].Breast Cancer Res Treat,2014,144(1):205-212.
